These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of age on the pharmacokinetics and pharmacodynamics of perindopril. Lees KR; Green ST; Reid JL Clin Pharmacol Ther; 1988 Oct; 44(4):418-25. PubMed ID: 2844467 [TBL] [Abstract][Full Text] [Related]
6. [Psychotropic effects of angiotensin-converting enzyme inhibitors: what are the arguments?]. Mesure G; Fallet A; Chevalier JF Encephale; 1995; 21(5):609-14. PubMed ID: 8529571 [TBL] [Abstract][Full Text] [Related]
7. Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients. Speirs C; Wagniart F; Poggi L Br J Clin Pharmacol; 1998 Jul; 46(1):63-70. PubMed ID: 9690951 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients. Suraniti S; Berrut G; Marre M; Fressinaud P Am J Cardiol; 1993 Jun; 71(17):28E-31E. PubMed ID: 8328364 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy. Bönner G; Lederle RM; Scholze J; Stumpe KO Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441 [TBL] [Abstract][Full Text] [Related]
13. Perindopril and pulmonary eosinophilic syndrome. Rochford AP; Smith PR; Khan SJ; Pearson AJ J R Soc Med; 2005 Apr; 98(4):163-5. PubMed ID: 15805558 [No Abstract] [Full Text] [Related]
14. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group. Overlack A; Adamczak M; Bachmann W; Bönner G; Bretzel RG; Derichs R; Krone W; Lederle RM; Reimann HJ; Zschiedrich H Am J Med; 1994 Aug; 97(2):126-34. PubMed ID: 8059778 [TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors and cough. Yeşil S; Yeşil M; Bayata S; Postaci N Angiology; 1994 Sep; 45(9):805-8. PubMed ID: 8092546 [TBL] [Abstract][Full Text] [Related]
16. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study]. Widimský J; Fedelesová V; Uhlír O Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker]. Rorive G; Creytens G; Ruhwiedel M; Van de Voorde K Rev Med Liege; 1990 Feb; 45(2):62-8. PubMed ID: 2180020 [No Abstract] [Full Text] [Related]